Inocras, a leader in whole genome sequencing and analytics driving precision health, has entered an agreement with researchers at the Broad Institute of MIT and Harvard for a joint analysis of whole-genome sequencing data from cancer.
Inocras, a leader in whole genome sequencing and analytics driving precision health, has entered an agreement with researchers at the Broad Institute of MIT and Harvard for a joint analysis of whole-genome sequencing data from cancer.
